Clinical Trials are a Lifeline. Access Shouldn't Be a Struggle.
Amanda Goh, Data Engineer, Data Melody
The Reality Patients Face Today
For many patients, finding a clinical trial is the last hope for survival. Clinical trials can represent hope, additional treatment options, and sometimes a final pathway when conventional treatments are no longer enough.
Yet today, finding relevant clinical trial information remains unexpectedly difficult.
The global clinical trial ecosystem is highly fragmented, with critical data dispersed across countless government registries, pharmaceutical platforms, hospital systems, and research institutions – each operating with different standards, structures, and levels of accessibility.
Patients and healthcare stakeholders are often left navigating disconnected sources, inconsistent information, and complex medical terminology simply to understand what opportunities may exist.
The Core Challenge
The challenge is no longer whether clinical trial information exists.
The challenge is whether that information can be discovered, understood, and accessed efficiently by the people who need it most.
Why We Started This Journey
We believe access to clinical trial information should not depend on a patient's ability to navigate fragmented systems, disconnected registries, or complex medical terminology.
As healthcare data continues to grow globally, the need for more accessible and structured clinical trial information becomes increasingly important.
This initiative represents the beginning of that effort.
Building a More Accessible Clinical Trial Ecosystem
At Data Melody Clinical Trial, we believe improving accessibility to trusted clinical trial information is an important healthcare technology challenge for the years ahead.
We are beginning this journey by building a more centralized and structured foundation for clinical trial information, starting with an initial footprint across 6 Asian and 5 European countries.
Our goal is to make clinical trial information more discoverable, understandable, and accessible for patients, caregivers, and healthcare stakeholders.
As the platform continues to evolve, we look forward to sharing more progress updates on our journey toward improving clinical trial accessibility and connectivity across fragmented information sources.
Progress Update — Building the Foundation for Better Clinical Trial Access
12th May 2026
Over the past week, we focused on collecting and organizing clinical trial data from several public registries and research sources across 6 Asian countries.
This marks an important foundation step toward improving access to fragmented clinical trial information across different regions and sources.
As development continues, we are actively working on improving data structure, consistency, and preparation for future integration workflows.
Progress Update — Structuring Patient-Focused Clinical Trial Information
19th May 2026
Over the past phase of development, we focused on transforming large volumes of raw clinical trial information into cleaner and more standardized patient-focused datasets.
This process involved organizing fragmented trial information from multiple public registries and research sources into more structured and consistent formats while maintaining structured datasets separately for each source.
The structured datasets currently include:
Clinical Trial Details
Patient Eligibility Criteria
Contact Information
This marks another important step toward improving the usability and organization of fragmented clinical trial information while preparing the foundation for future cross-source integration workflows.
As development continues, we are actively working on improving cross-source consistency, matching logic, and dataset standardization workflows.
Progress Update — Merged & Consolidated Clinical Trial Data
26th May 2026
Over the past phase of development, we focused on merging and consolidating structured clinical trial datasets collected from multiple public registries and research sources into a more unified data foundation.
This process involved identifying overlapping trial information across different sources, improving cross-source consistency, and organizing fragmented records into cleaner and more structured datasets.
Many clinical trials contain overlapping information across multiple registries and research sources, making duplicate handling and structured consolidation important parts of the integration process.
As part of this progress, we successfully:
Merged structured clinical trial datasets across multiple sources
Improved duplicate handling and cross-source consistency
Strengthened dataset standardization workflows
As development continues, we are actively refining the organization and structuring of consolidated datasets to support more accessible and analysis-ready outputs.
Progress Update — Structured Clinical Trial Exports
1st Jun 2026
Following the consolidation of structured clinical trial datasets, we focused on organizing processed information into structured exports for downstream analysis and review purposes.
This phase improved the organization, accessibility, and usability of consolidated clinical trial information by transforming processed datasets into more structured and analysis-ready outputs.
The resulting outputs were organized into:
Clinical Trial Details
Patient Eligibility Criteria
Contact Information
Structured export workflows help make consolidated clinical trial information easier to review, analyze, and utilize across different operational and analytical workflows.
As development continues, we are actively preparing for the expansion of additional clinical trial data sources while continuing to improve dataset organization and export consistency.
Follow our future updates and progress at Data Melody: